RVL Pharmaceuticals plc carries a market capitalization of 3.14M, placing it among publicly traded companies globally.
| Market Cap | 3.14M |
| Enterprise Value | N/A |
RVL Pharmaceuticals plc's stock has declined approximately -98.08163% over the past 52 weeks. The 50-day moving average sits at 0.09, while the 200-day moving average is 0.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | -98.08163% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.66 |
| Average Volume (20 Days) | N/A |